Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has launched Pemetrexed for Injection, 100 mg and 500 mg Single-Dose Vials, the generic equivalent of ALIMTA (pemetrexed for injection) in the US Market approved by the U.S. Food and Drug Administration (USFDA).

The ALIMTA brand and generic had U.S. sales of approximately $1239 million MAT for the most recent twelve months ending in March 2022 according to IQVIA Health. The company’s Pemetrexed for Injection, is supplied in 100 mg and 500 mg single-dose vials.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.